Daylife Select
A point & click tool to create dynamic content portals. Learn More »
Editor's Picks
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
-
2009-12-10 22:40:34 - Abbott Laboratories Market Share Analysis - a new market research report on companiesandmarkets.com and products, and provides an analysis of its key medical equipment revenue lines. Full Article at PR-Inside.com
-
2009-12-10 21:10:33 - Inc. integration team charged with the successful and timely integration of Ovation Pharmaceuticals into Lundbeck. Full Article at PR-Inside.com
-
A woman enters the headquarters of Belgian drugs, chemicals and plastics maker Solvay in Brussels, September 28, 2009. View Photo »
-
The campaign is inviting the companies, which include Abbott Laboratories, GlaxoSmithKline, and Pfizer, to place the patents for a list of HIV drugs into a patent pool recently set up by Unitaid, an international agency that partners with organisations including the World Health Organization and UNAIDS ...
SOURCE: Medical News Today -
Abbott Laboratories (NYSE: ABT) has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) for two new dosage strengths of SIMCOR, a cholesterol medication. Full Article at Street Insider
-
NEW YORK: As many as nine transactions, including Pfizer's takeover of Wyeth Corp and Merck & Co's buying of Schering-Plough Corp, are under investigation by the US regulator Securities and Exchange Commission for possible insider-trading violations,... Full Article at Times of India
-
Research and Markets: Study the Annualized Global Glucose Monitoring Systems Market Revenues Data from 2001 to 2008, Forecast Forward ..
PR-Inside.com
2009-12-09 17:23:45 - the key trends shaping and driving the dynamism in the global glucose monitoring systems market. Full Article at PR-Inside.com
-
A view of the logo of Belgian drugs, chemicals and plastics maker Solvay in Brussels, September 28, 2009. View Photo »
-
Genetic biomarkers are at the heart of the new prostate cancer tests we have licensed to Quest Diagnostics and Abbott Laboratories. Combined with our sophisticated analysis tools for identifying positive results from massive amounts of previously unusable clinical data, biomarkers like those patented by...
SOURCE: Freshnews.com -
-
WASHINGTON — The advertisement for an athlete's foot drug depicted attacks on a giant fungus alongside the words Crush, Kill and Destroy in bold type. Full Article at St. Louis Post-Dispatch
-
Abbott Laboratories (ABT) is in a great spot, according to Sanford C. Bernstein analyst Derrick Sung. "They're one of my top picks," he said. The drugmaker makes a number of notable names, but two to watch are Humira and Xience. Full Article at Investor's Business Daily
About Abbott Laboratories
Wikipedia
There are no results for this module. Edit this module to change the search term used to query Wikipedia
Related Photos
prev
next
-
Reuters Pictures
A woman enters the headquarters of Belgian drugs, chemicals and plastics maker Solvay in Brussels, September 28, 2009. Solvay said on Monday it would sell its drugs unit to U.S. partner Abbott Laboratories for 4.5 billion euros ($6.6 billion) in cash and reinvest in chemicals and plastics.
View Photo » -
Reuters Pictures
A view of the logo of Belgian drugs, chemicals and plastics maker Solvay in Brussels, September 28, 2009. Solvay said on Monday it would sell its drugs unit to U.S. partner Abbott Laboratories for 4.5 billion euros ($6.6 billion) in cash and reinvest in chemicals and plastics.
View Photo » -
Reuters Pictures
Belgium's Christian Jourquin, chief executive officer of Belgian drugs, chemicals and plastics maker Solvay, holds a news conference in Brussels, September 28, 2009.
View Photo » -
Reuters Pictures
Christian Jourquin, chief executive officer of Belgian drugs, chemicals and plastics maker Solvay, holds a news conference in Brussels, September 28, 2009.
View Photo » -
Reuters Pictures
Christian Jourquin, chief executive officer of Belgian drugs, chemicals and plastics maker Solvay, holds a news conference in Brussels, September 28, 2009.
View Photo » -
Reuters Pictures
Christian Jourquin, chief executive officer of Belgian drugs, chemicals and plastics maker Solvay, holds a news conference in Brussels, September 28, 2009.
View Photo » -
AP Photo
FILE - In this July 13, 2005 file photo provided by Abbott Laboratories, the North Chicago-based company's rheumatoid arthritis therapy Humira, is shown.
View Photo » -
AP Photo
FILE - In this July 13, 2005 file photo provided by Abbott Laboratories, the North Chicago-based company's rheumatoid arthritis therapy Humira, is shown.
View Photo » -
AP Photo
AIDS Healthcare Foundation advocates, joined by Chicago-area medical student activists and the Chicago Women's AIDS Project, protested today outside the Lake Forest, IL home of Abbott Laboratories' CEO Miles D. White over the company's AIDS drug prices in Mexico and Colombia.
View Photo »
Reuters Pictures
A view of the logo of Belgian drugs, chemicals and plastics maker Solvay in Brussels, September 28, 2009. Solvay said on Monday it would sell its drugs unit to U.S. partner Abbott Laboratories for 4.5 billion euros ($6.6 billion) in cash and reinvest in chemicals and plastics.
View Photo »
